HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p.

Abstract
Therapeutic strategies for targeting angiogenesis have been proven as successful treatments for divergent cancers. We previously discovered an anti-angiogenic miR-542-3p, which directly targeted the key angiogenesis-promoting protein Angiopoietin-2 to inhibit tumor angiogenesis in breast cancer models. In this study, to further investigate the mechanism of miR-542-3p induced angiogenic inhibition, we screened for tumor cell derived factors which were responsible for miR-542-3p alteration in endothelial cells. We found that tumor cell-derived angiogenin downregulated miR-542-3p in endothelial cells. Overexpression of angiogenin in tumor cells facilitated angiogenic activation in both in vitro and in vivo models via inhibition of miR-542-3p. Furthermore, our results showed that angiogenin could suppress CEBPB and POU2F1, which were transcription factors for miR-542-3p, suggesting a novel tumor cell-endothelial cell signal pathway. In addition, the level of angiogenin in primary breast carcinomas correlated with clinical progression. Serum levels of angiogenin were associated with metastatic development of breast cancer patients. Together, these findings reveal a novel regulatory pathway whereby tumor-derived angiogenin directly activates angiogenesis through inhibition of miR-542-3p, suggesting that angiogenin may represent a promising target for anti-angiogenic therapy and a potential marker for monitoring disease progression.
AuthorsTing He, Feifei Qi, Lin Jia, Shan Wang, Chunying Wang, Nan Song, Yan Fu, Lin Li, Yongzhang Luo
JournalCancer letters (Cancer Lett) Vol. 368 Issue 1 Pg. 115-125 (Nov 01 2015) ISSN: 1872-7980 [Electronic] Ireland
PMID26272182 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • CCAAT-Enhancer-Binding Protein-beta
  • CEBPB protein, human
  • Culture Media, Conditioned
  • MIRN542 microRNA, human
  • MicroRNAs
  • Octamer Transcription Factor-1
  • POU2F1 protein, human
  • angiogenin
  • Ribonuclease, Pancreatic
Topics
  • Animals
  • Breast Neoplasms (blood supply, genetics, metabolism)
  • CCAAT-Enhancer-Binding Protein-beta (metabolism)
  • Cell Line, Tumor
  • Culture Media, Conditioned
  • Down-Regulation
  • Female
  • Gene Expression Regulation, Neoplastic
  • HEK293 Cells
  • Human Umbilical Vein Endothelial Cells (metabolism)
  • Humans
  • Mice, Inbred BALB C
  • Mice, Nude
  • MicroRNAs (genetics, metabolism)
  • Neovascularization, Physiologic
  • Octamer Transcription Factor-1 (metabolism)
  • Paracrine Communication
  • Ribonuclease, Pancreatic (genetics, metabolism)
  • Signal Transduction
  • Time Factors
  • Transcription, Genetic
  • Transfection
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: